Caris Life Sciences, Inc.CAI
NasdaqGS•Healthcare•Biotechnology
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $1.03B. TTM net income stood at $-68.60M. Quarterly EBITDA was $10.35M and operating income was $5.28M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze CAI growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters